Annual Net Income
-$60.40 M
+$13.79 M+18.59%
31 December 2023
Summary:
AC Immune SA annual net profit is currently -$60.40 million, with the most recent change of +$13.79 million (+18.59%) on 31 December 2023. During the last 3 years, it has risen by +$5.65 million (+8.55%). ACIU annual net income is now -232.04% below its all-time high of $45.74 million, reached on 31 December 2019.ACIU Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$6.36 M
+$31.53 M+125.29%
01 September 2024
Summary:
AC Immune SA quarterly net profit is currently $6.36 million, with the most recent change of +$31.53 million (+125.29%) on 01 September 2024. Over the past year, it has increased by +$23.51 million (+137.11%). ACIU quarterly net income is now -90.03% below its all-time high of $63.80 million, reached on 31 March 2019.ACIU Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$44.59 M
+$23.51 M+34.52%
01 September 2024
Summary:
AC Immune SA TTM net profit is currently -$44.59 million, with the most recent change of +$23.51 million (+34.52%) on 01 September 2024. Over the past year, it has increased by +$29.68 million (+39.96%). ACIU TTM net income is now -187.95% below its all-time high of $50.70 million, reached on 30 September 2019.ACIU TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACIU Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +18.6% | +137.1% | +40.0% |
3 y3 years | +8.6% | +136.7% | +43.1% |
5 y5 years | -16.0% | -65.6% | -187.9% |
ACIU Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +24.4% | at high | +125.3% | at high | +45.5% |
5 y | 5 years | -232.0% | +24.4% | -65.6% | +125.3% | -187.9% | +45.5% |
alltime | all time | -232.0% | +24.4% | -90.0% | +125.3% | -187.9% | +45.5% |
AC Immune SA Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $6.36 M(-125.3%) | -$44.59 M(-34.5%) |
June 2024 | - | -$25.17 M(+23.1%) | -$68.10 M(+10.4%) |
Mar 2024 | - | -$20.44 M(+281.8%) | -$61.67 M(+2.5%) |
Dec 2023 | -$60.40 M(-18.6%) | -$5.35 M(-68.8%) | -$60.14 M(-19.0%) |
Sept 2023 | - | -$17.15 M(-8.4%) | -$74.27 M(+4.4%) |
June 2023 | - | -$18.73 M(-1.0%) | -$71.12 M(-2.2%) |
Mar 2023 | - | -$18.91 M(-2.9%) | -$72.74 M(-2.0%) |
Dec 2022 | -$74.19 M(-7.1%) | -$19.49 M(+39.2%) | -$74.24 M(-4.6%) |
Sept 2022 | - | -$13.99 M(-31.2%) | -$77.84 M(-4.1%) |
June 2022 | - | -$20.35 M(-0.3%) | -$81.18 M(-0.7%) |
Mar 2022 | - | -$20.41 M(-11.6%) | -$81.76 M(+2.4%) |
Dec 2021 | -$79.87 M(+20.9%) | -$23.08 M(+33.1%) | -$79.86 M(+1.9%) |
Sept 2021 | - | -$17.34 M(-17.2%) | -$78.35 M(-4.1%) |
June 2021 | - | -$20.94 M(+13.2%) | -$81.67 M(+6.0%) |
Mar 2021 | - | -$18.50 M(-14.3%) | -$77.06 M(+15.9%) |
Dec 2020 | -$66.05 M(-244.4%) | -$21.58 M(+4.5%) | -$66.51 M(+3.0%) |
Sept 2020 | - | -$20.65 M(+26.5%) | -$64.58 M(+153.9%) |
June 2020 | - | -$16.33 M(+105.5%) | -$25.44 M(-2.0%) |
Mar 2020 | - | -$7.95 M(-59.6%) | -$25.96 M(-156.7%) |
Dec 2019 | $45.74 M | -$19.64 M(-206.3%) | $45.79 M(-9.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2019 | - | $18.48 M(-209.7%) | $50.70 M(+174.4%) |
June 2019 | - | -$16.85 M(-126.4%) | $18.48 M(-23.1%) |
Mar 2019 | - | $63.80 M(-533.0%) | $24.02 M(-146.2%) |
Dec 2018 | -$52.08 M(+94.3%) | -$14.74 M(+7.3%) | -$52.03 M(+57.3%) |
Sept 2018 | - | -$13.74 M(+21.4%) | -$33.08 M(+16.2%) |
June 2018 | - | -$11.31 M(-7.6%) | -$28.48 M(-4.0%) |
Mar 2018 | - | -$12.25 M(-390.4%) | -$29.68 M(+10.5%) |
Dec 2017 | -$26.81 M(+272.2%) | $4.22 M(-146.2%) | -$26.85 M(-25.1%) |
Sept 2017 | - | -$9.13 M(-27.0%) | -$35.83 M(-0.5%) |
June 2017 | - | -$12.51 M(+32.9%) | -$36.02 M(+253.9%) |
Mar 2017 | - | -$9.41 M(+97.7%) | -$10.18 M(+45.9%) |
Dec 2016 | -$7.20 M(-134.2%) | -$4.76 M(-48.9%) | -$6.98 M(-11.1%) |
Sept 2016 | - | -$9.33 M(-170.0%) | -$7.85 M(-135.2%) |
June 2016 | - | $13.33 M(-314.5%) | $22.31 M(+23.3%) |
Mar 2016 | - | -$6.22 M(+10.3%) | $18.10 M(-14.6%) |
Dec 2015 | $21.06 M(+79.2%) | -$5.63 M(-127.0%) | $21.20 M(-21.0%) |
Sept 2015 | - | $20.83 M(+128.6%) | $26.83 M(+347.2%) |
June 2015 | - | $9.11 M(-392.7%) | $6.00 M(-292.7%) |
Mar 2015 | - | -$3.11 M | -$3.11 M |
Dec 2014 | $11.76 M | - | - |
FAQ
- What is AC Immune SA annual net profit?
- What is the all time high annual net income for AC Immune SA?
- What is AC Immune SA annual net income year-on-year change?
- What is AC Immune SA quarterly net profit?
- What is the all time high quarterly net income for AC Immune SA?
- What is AC Immune SA quarterly net income year-on-year change?
- What is AC Immune SA TTM net profit?
- What is the all time high TTM net income for AC Immune SA?
- What is AC Immune SA TTM net income year-on-year change?
What is AC Immune SA annual net profit?
The current annual net income of ACIU is -$60.40 M
What is the all time high annual net income for AC Immune SA?
AC Immune SA all-time high annual net profit is $45.74 M
What is AC Immune SA annual net income year-on-year change?
Over the past year, ACIU annual net profit has changed by +$13.79 M (+18.59%)
What is AC Immune SA quarterly net profit?
The current quarterly net income of ACIU is $6.36 M
What is the all time high quarterly net income for AC Immune SA?
AC Immune SA all-time high quarterly net profit is $63.80 M
What is AC Immune SA quarterly net income year-on-year change?
Over the past year, ACIU quarterly net profit has changed by +$23.51 M (+137.11%)
What is AC Immune SA TTM net profit?
The current TTM net income of ACIU is -$44.59 M
What is the all time high TTM net income for AC Immune SA?
AC Immune SA all-time high TTM net profit is $50.70 M
What is AC Immune SA TTM net income year-on-year change?
Over the past year, ACIU TTM net profit has changed by +$29.68 M (+39.96%)